Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=211"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=211

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT04020341-6cb4949c",
        "title": "Gepotidacin vs Nitrofurantoin: Number of Participants With Treatment-emergent Adverse Events (TEAEs)",
        "summary": "266 of 766 against 165 of 760; risk difference 13.0 points, 95% interval 8.5 to 17.4; NCT04020341, A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)",
        "record": "/library/comparisons/NCT04020341-6cb4949c",
        "nct_id": "NCT04020341",
        "kind": "outcome",
        "participants": 1526,
        "risk_difference": {
          "value": 0.13015322248179195,
          "lower": 0.08517439898124718,
          "upper": 0.17441462179257505
        },
        "group_1": "266 of 766",
        "group_2": "165 of 760",
        "difference": "13.0 points",
        "interval": "8.5 to 17.4",
        "trial_title": "A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)"
      },
      {
        "id": "NCT04020341-ca85f5ef",
        "title": "Gepotidacin vs Nitrofurantoin: Number of Participants With Serious Adverse Events (SAEs)",
        "summary": "2 of 766 against 3 of 760; risk difference -0.1 points, 95% interval -0.9 to 0.6; NCT04020341, A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)",
        "record": "/library/comparisons/NCT04020341-ca85f5ef",
        "nct_id": "NCT04020341",
        "kind": "outcome",
        "participants": 1526,
        "risk_difference": {
          "value": -0.0013364023636113784,
          "lower": -0.009162648299922586,
          "upper": 0.005999833245539605
        },
        "group_1": "2 of 766",
        "group_2": "3 of 760",
        "difference": "-0.1 points",
        "interval": "-0.9 to 0.6",
        "trial_title": "A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=212",
  "request_id": "El5OiJ1i4UIKgYZr"
}